OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myelomaIeuan Walker, Michael Chapman, Venetia D’Arcy et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0